ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
SP
STCube Pharmaceuticals at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
STCube Pharmaceuticals takes part in 3 sessions at ESMO 2026 in Madrid. Its work examines BTN1A1 in lung and colorectal cancers, including treatment resistance. One study evaluates nelmastobart with docetaxel in relapsed non-small-cell lung cancer expressing BTN1A1.
| Organization | ESMO 2026 Attendance |
|---|---|
SP STCube Pharmaceuticals Rockville, MD | |
Biotechnology company developing cancer therapeutics. | Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Cell DIVE profiling of BTN1A1-associated spatial TME phenotypes in refractory CRC Gastrointestinal cancers |
Find decision makers at STCube Pharmaceuticals
Tell us what you sell and we’ll find the people at STCube Pharmaceuticals most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction